Commercialization: Page
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Early-stage commercial spending can top $60 million for blockbuster products, according to Cutting Edge Information. With such high commercial investments come equally elevated risks that drugs will fail to reach the market or achieve less than their full commercial potential. It is critical that...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
-
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on Your Mind — Opinions More on the New DTC Guidelines PharmaVOICE received an overwhelming number of responses to our January opinion question, which addressed the FDA proposed changes to the regulations that govern the content and format of the product disclaimer or brief summary that mu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
May 2004 The forum for the industry executive Narrowing the GAP Between R&D and Marketing Building Strategic Teams with Marsha Fanucci Trial Coordinators The Front Line Building Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL David J. Kudla Jr. Advancis Creates VP of Quality Assurance Position Advancis Pharmaceutical, a pharmaceutical company focused on developing and commercializing novel anti-infective products, has named David ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Building Bridges: Bringing R&D and Marketing Closer
By Elisabeth Pena Building Bridges and Closer Bringing R&D Marketing Pharmaceutical companies must connect science and marketing at the earliest development stages to optimize resource allocation and produce profitable products. The Bridge Builders Gina Ashe. VP, Marketing and Product Develop...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Christopher Clement Savient Pharmaceuticals Names CEO Savient Pharmaceuticals has named Christopher Clement CEO, in addition to his role as president. Savient, East Brunswick, N.J., is engaged in developing, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Beyond Passwords
Beyond Passwords By Denise Myshko Biometrics – technologies that allow people to be identified by fingerprints or other biological markers, such as iris scans – is receiving increased attention by companies in many industries concerned about security, not only for their premises but also for thei...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Trials Around the World
Trials Around the World By Denise Myshko Many pharmaceutical companies and CROs are tapping Eastern Europe, Asia, Latin America, and other areas to meet their clinical-trial needs. While there are challenges associated with conducting research in nontraditional geographic regions – such as nascen...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Joy A. Amundson Bruce McGillivray Jim Utts Baxter Appoints and Promotes Executives Baxter International has named Joy A. Amundson corporate VP and president of its bioscience business. Baxter, Deerfield, Ill....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Kareem Saad -- Big Blue's Genomics Ace
By Kim Ribbink Big Blue’s Genomics Ace Young and talented, Kareem Saad, IBM’s worldwide business segment executive for clinical genomics, is overseeing the company’s initiative to take clinical genomics from concept to market. With youthful enthusiasm, innate technical and scientific intelligence...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Life-Cycle Management: The Ultimate Client-Agency Relationship
Life-cycle Management The Ultimate Client-Agency Relationship By Elisabeth Pena With $80 billion of products facing patent expiration by 2008, fewer drugs in the pipeline, greater generic competition, and decreasing revenue and growth rates, the pharmaceutical industry is facing some of its bigge...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Improving Advocacy Relations
Improving Advocacy relations By Elisabeth Pena By forming relationships with advocacy organizations, pharmaceutical companies can better serve their target patient populations, which in turn will give them allies in the court of public opinion. P harmaceutical companies are in the middle of a pub...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends Affecting the Healthcare Industry Public Awareness of Clinical Trials Grows Awareness of clinical trials among the general public has grown over the last three years, while physicians struggle to find the time, personnel, and resources to participa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter From The Editor Defining Leadership According to noted author John C. Maxwell, the definition of leadership is influence. Influence — the power to affect a person, thing, or course of events, especially one that operates without any direct or apparent effort — requires a commitment to furt...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Medicare Part D: It’s “Crunch Time” and Many Brand Teams Aren’t Ready “If Medco called tomorrow to ask how I would contract my product under Part D, I couldn’t tell them. The trouble is, they just might call tomorrow!” I’ve heard similar quotes from numerous brand directors over the past month as...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: PRA International Launches Pediatric Clinical Development and Research Center PhRMA Adopts Clinical-Trial Principles LabConnect Completes inREACH Acquisition Life Science Insights Offers Intelligence Service GSP C...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive Appointments and Promotions in the Healthcare Industry Featured Talent: Pharma POOL Joy A. Amundson, Baxter International Bruce McGillivray, Baxter International Jim Utts, Baxter International Brian Crombie , Biovail David Keefer, Biovail Charles Rowland, Biovail Paul Duffy, Ala...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Raise your voice Letters Times have changed In today’s highly competitive environment, experience and training together will be of great help in the development of managers. — Avinash L. Salunke Manager development The April 2004 story, Coaching: Developing a Playbook for Sales Rep Success, was v...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends affecting the healthcare industry The Biodefense Market to Grow Biodefense research is one of the fastest growing markets for suppliers of life-sciences products and instrumentation. When the budget allocated to the Department of Health and Human S...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a Case for Rebranding The Rebranding of a Brander Healthcare advertising agencies, among their many strategic and creative services, excel at branding or rebranding pharmaceutical products, devices, diagnostics, and corporate identities for their clients. Harder to do is to apply those sam...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies PhRMA Adopts Clinical-Trial Principles Voluntary principles describe the relationship of PhRMA companies with others involved in clinical research and establish the rules to protect the safety of research participants. The Pharma...
By PharmaVoice Team • Jan. 2, 2008
Previous
